Nexgel (NXGL) Liabilities and Shareholders Equity (2018 - 2025)
Nexgel (NXGL) reported Liabilities and Shareholders Equity of $10.5 million for Q4 2025, down 4.75% on a YoY basis from $11.0 million in Q4 2024, and down 9.97% quarter-over-quarter from $11.6 million in Q3 2025.
Nexgel (NXGL) Liabilities and Shareholders Equity (2018 - 2025) Analysis & Trends
Nexgel has reported Liabilities and Shareholders Equity for 8 years, with the latest figure at $10.5 million in Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 4.75% year-over-year to $10.5 million; the trailing twelve-month figure through Dec 2025 stood at $42.2 million (up 1.23% YoY), and the FY2025 full-year result was $10.5 million, down 4.75% from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $10.5 million, down from $11.6 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $17.0 million in Q4 2021, with the low at $3.4 million in Q1 2021.
- Historically, Liabilities and Shareholders Equity has averaged $10.2 million across 5 years, with a median of $10.4 million in 2025.
- Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity soared 652.46% — and 2022, when it plunged 39.02%.
- Nexgel's Liabilities and Shareholders Equity stood at $17.0 million in 2021, then sank by 39.02% to $10.4 million in 2022, then declined by 3.88% to $10.0 million in 2023, then advanced by 10.33% to $11.0 million in 2024, then decreased by 4.75% to $10.5 million in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $10.5 million (Q4 2025), $11.6 million (Q3 2025), and $9.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Nexgel | 4.18 Mn | 2.81 Mn | 819,000.00 | 10.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.46 Mn |
| Sep 30, 2025 | 11.62 Mn |
| Jun 30, 2025 | 9.71 Mn |
| Mar 31, 2025 | 10.44 Mn |
| Dec 31, 2024 | 10.98 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Jun 30, 2024 | 9.78 Mn |
| Mar 31, 2024 | 10.39 Mn |
| Dec 31, 2023 | 9.96 Mn |
| Sep 30, 2023 | 9.95 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | 11.01 Mn |
| Dec 31, 2022 | 10.36 Mn |
| Sep 30, 2022 | 11.23 Mn |
| Jun 30, 2022 | 13.77 Mn |
| Mar 31, 2022 | 14.08 Mn |
| Dec 31, 2021 | 16.98 Mn |
| Sep 30, 2021 | 4.94 Mn |
| Jun 30, 2021 | 4.11 Mn |
| Mar 31, 2021 | 3.43 Mn |